EGFR and neoplasm: At all doses, the free EGFR in the stroma-rich areas (as indicated by the dash lines) was suppressed to a higher degree, primarily because of a relatively lower fraction of EGFR-positive tumor cells and a tighter antibody-EGFR binding in the stromal-rich tumor areas.